statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	21.329
EU - Europa	10.302
AS - Asia	7.976
SA - Sud America	1.023
AF - Africa	209
OC - Oceania	47
Continente sconosciuto - Info sul continente non disponibili	12
Totale	40.898

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	21.112
IT - Italia	4.950
SG - Singapore	2.672
CN - Cina	2.026
UA - Ucraina	1.554
VN - Vietnam	1.086
HK - Hong Kong	961
BR - Brasile	846
TR - Turchia	689
SE - Svezia	649
GB - Regno Unito	572
IE - Irlanda	550
DE - Germania	465
FI - Finlandia	460
FR - Francia	386
RU - Federazione Russa	301
IN - India	117
NL - Olanda	113
MX - Messico	107
NG - Nigeria	100
CA - Canada	90
AT - Austria	73
AR - Argentina	66
JP - Giappone	64
BD - Bangladesh	61
IQ - Iraq	41
PL - Polonia	39
AU - Australia	34
ZA - Sudafrica	30
BE - Belgio	28
ES - Italia	28
SA - Arabia Saudita	28
EC - Ecuador	27
ID - Indonesia	27
PK - Pakistan	26
CZ - Repubblica Ceca	23
KR - Corea	23
MA - Marocco	22
CL - Cile	18
CH - Svizzera	17
UZ - Uzbekistan	17
VE - Venezuela	16
CO - Colombia	15
MY - Malesia	15
PE - Perù	14
TW - Taiwan	13
NZ - Nuova Zelanda	12
AE - Emirati Arabi Uniti	11
DZ - Algeria	11
EU - Europa	11
HU - Ungheria	11
KZ - Kazakistan	11
JO - Giordania	10
LT - Lituania	10
RO - Romania	10
KE - Kenya	9
NP - Nepal	9
PY - Paraguay	9
AL - Albania	8
AZ - Azerbaigian	8
EG - Egitto	8
PH - Filippine	8
BO - Bolivia	7
IR - Iran	7
NO - Norvegia	7
OM - Oman	7
PT - Portogallo	7
TH - Thailandia	7
TN - Tunisia	7
GR - Grecia	6
MD - Moldavia	6
SK - Slovacchia (Repubblica Slovacca)	6
DK - Danimarca	5
SN - Senegal	5
BG - Bulgaria	4
BH - Bahrain	4
CI - Costa d'Avorio	4
LK - Sri Lanka	4
UY - Uruguay	4
BA - Bosnia-Erzegovina	3
BY - Bielorussia	3
CR - Costa Rica	3
HN - Honduras	3
IL - Israele	3
KH - Cambogia	3
LB - Libano	3
LY - Libia	3
MM - Myanmar	3
PA - Panama	3
BB - Barbados	2
GD - Grenada	2
GE - Georgia	2
GN - Guinea	2
HR - Croazia	2
LU - Lussemburgo	2
RS - Serbia	2
SY - Repubblica araba siriana	2
TT - Trinidad e Tobago	2
ZM - Zambia	2
BN - Brunei Darussalam	1
Totale	40.875

Salva come PNG Salva come JPEG

Città	#
Milan	3.409
Fairfield	2.338
Woodbridge	1.831
Ashburn	1.688
Singapore	1.440
San Jose	1.436
Jacksonville	1.258
Houston	1.212
Ann Arbor	1.207
Chandler	1.100
Hong Kong	948
Wilmington	929
Seattle	927
Cambridge	788
Dallas	551
Dublin	532
Princeton	532
Shenzhen	465
Dearborn	410
Boardman	380
The Dalles	380
Izmir	372
Nyköping	314
Chicago	304
Beijing	291
Dong Ket	285
Lauterbourg	284
Rome	279
Council Bluffs	231
New York	188
Ho Chi Minh City	183
San Diego	169
London	152
Hanoi	134
Como	126
Los Angeles	126
Helsinki	123
San Mateo	120
Ogden	104
Abuja	95
Santa Clara	91
São Paulo	88
Hefei	77
Mexico City	70
Munich	70
Guangzhou	69
Washington	65
Falls Church	57
Tokyo	57
Kocaeli	49
Shanghai	46
Orem	45
Nanjing	44
Nuremberg	43
Frankfurt am Main	41
Vienna	41
Kunming	39
San Francisco	39
Amsterdam	38
Salt Lake City	38
Norwalk	36
Phoenix	35
Toronto	35
Chennai	34
Rio de Janeiro	32
San Genesio Ed Uniti	32
Brooklyn	31
Warsaw	31
Tianjin	29
Verona	29
Atlanta	28
Columbus	27
Hangzhou	26
Jinan	26
Montreal	25
Brussels	24
Zhengzhou	24
Düsseldorf	23
Redmond	23
Redwood City	22
Tampa	22
Da Nang	21
Haiphong	21
Buffalo	20
Belo Horizonte	19
Stockholm	19
Magnago	18
Pavia	18
Philadelphia	18
Elk Grove Village	17
Johannesburg	17
Kilburn	17
Manchester	17
Shenyang	17
Baghdad	16
Brno	16
Dhaka	16
Nanchang	16
Ankara	15
Chengdu	15
Totale	29.675

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	587
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	329
The effects of a cognitive behavioural intervention in asthmatic patients.	293
Airway inflammation in patients affected by obstructive sleep apnea	288
Classifying new anti-tuberculosis drugs: rationale and future perspectives	244
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.	241
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	234
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	230
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	229
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	227
Aging and airway inflammation	223
Aging and induced-sputum cells.	215
A new Editorial Board of Monaldi Archives for Chest Disease	213
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	211
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	211
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	211
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance.	209
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	209
Clinical and operational value of the extensively drug-resistant tuberculosis definition.	208
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	208
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.	206
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	206
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.	203
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	196
Brittle Asthma	195
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics.	195
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	195
Ripped from the headlines: how can we harness communications to control TB?	194
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	194
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	193
Improving the TB case management: The International Standards for Tuberculosis Care.	192
Tuberculosis elimination: theory and practice in Europe	192
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	192
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.	191
History of tuberculosis and drug resistance	191
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	189
Economic analysis of two structured treatment and teaching programs on asthma.	189
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.	189
When kidneys and lungs suffer together	189
Induced sputum to assess airway inflammation: a study of reproducibility.	188
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate.	188
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	188
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	187
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	187
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	187
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	187
In vitro susceptibility testing and totally drug-resistant tuberculosis	186
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	185
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.	184
AIDS and tuberculosis control programmes: an integrated approach at educational level.	183
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.	182
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.	182
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution.	182
Effect of methacholine challenge on cellular composition of sputum induction.	181
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	181
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.	180
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	180
Effects of intradermal injection of atrial natriuretic peptide.	180
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	180
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	180
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	180
Sputum induced cellularity in a group of traffic policemen.	179
Comparison of two methods of processing induced sputum: selected versus entire sputum.	177
European union standards for tuberculosis care.	177
Airway inflammation in healthy smokers.	177
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.	176
An electronic nose in the discrimination of patients with asthma and controls.	176
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	176
Latex allergy and sensitization in cities: a survey in a population at risk	176
Menopausal asthma: a new biological phenotype?	175
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	174
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.	174
Recent developments in the diagnosis and management of tuberculosis	174
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	174
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	174
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact.	173
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	171
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.	170
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy	170
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	170
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.	169
Assembly 5: Airway diseases	169
Exhaled inflammatory markers in aspirin-induced asthma syndrome.	168
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.	167
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	167
Is bronchodilator the correct treatment for COPD subjects before EBUS?	167
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	166
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.	166
SPUTUM AND EXHALED BREATH ANALYSIS	165
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.	164
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	164
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses	164
Tuberculosis elimination: Where are we now?	162
The mechanics of the lung parenchyma and airway responsiveness to metacholine.	161
Management of drug resistantTB in patients with HIV co-infection	161
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD	160
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	160
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial	160
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	159
Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients	158
Totale	19.339

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	174.701
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	174.701

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.394	0	0	0	0	0	0	0	0	0	283	418	693
2021/2022	2.742	315	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	4.451	53	93	781	151	180	355	163	271	523	447	319	1.115
2025/2026	9.311	539	566	685	1.167	703	520	2.556	682	1.351	542	0	0
Totale													41.564